Skip to content
10-Q

Quarterly Report

SYNEOS HEALTH, INC.

0000950170-22-022013

← back to feed
Filed
Nov 4, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Oct 31, 2022 102.9M sh
Shares Diluted Q3 2022 · Sep 30, 2022 103.21M sh
Shares Diluted Q3 2022 · Sep 30, 2022 103.56M sh
Shares Diluted Q3 2022 · Sep 30, 2021 104.79M sh
Shares Diluted Q3 2022 · Sep 30, 2021 105.09M sh
Stock Repurchased Q3 2022 · Sep 30, 2022 $149.96M
Stock Repurchased Q3 2022 · Sep 30, 2021 $117.52M
Capex Q3 2022 · Sep 30, 2022 $69.83M
Capex Q3 2022 · Sep 30, 2021 $29.92M
Operating Cash Flow Q3 2022 · Sep 30, 2022 $303.16M
Operating Cash Flow Q3 2022 · Sep 30, 2021 $264.3M
Long Term Debt Q3 2022 · Sep 30, 2022 $2.75B
Long Term Debt Q3 2022 · Dec 31, 2021 $2.78B
Stockholders Equity Q3 2022 · Sep 30, 2022 $3.35B
Stockholders Equity Q3 2022 · Jun 30, 2022 $3.33B
Stockholders Equity Q3 2022 · Dec 31, 2021 $3.41B
Stockholders Equity Q3 2022 · Sep 30, 2021 $3.32B
Stockholders Equity Q3 2022 · Jun 30, 2021 $3.24B
Stockholders Equity Q3 2022 · Dec 31, 2020 $3.24B
Current Liabilities Q3 2022 · Sep 30, 2022 $1.72B
Current Liabilities Q3 2022 · Dec 31, 2021 $1.65B
Total Liabilities Q3 2022 · Sep 30, 2022 $4.84B
Total Liabilities Q3 2022 · Dec 31, 2021 $4.82B
Current Assets Q3 2022 · Sep 30, 2022 $1.96B
Current Assets Q3 2022 · Dec 31, 2021 $1.77B
Total Assets Q3 2022 · Sep 30, 2022 $8.2B
Total Assets Q3 2022 · Dec 31, 2021 $8.24B
Eps Diluted Q3 2022 · Sep 30, 2022 $0.84
Eps Diluted Q3 2022 · Sep 30, 2022 $2.04
Eps Diluted Q3 2022 · Sep 30, 2021 $0.75
Eps Diluted Q3 2022 · Sep 30, 2021 $1.51
Eps Basic Q3 2022 · Sep 30, 2022 $0.85
Eps Basic Q3 2022 · Sep 30, 2022 $2.05
Eps Basic Q3 2022 · Sep 30, 2021 $0.76
Eps Basic Q3 2022 · Sep 30, 2021 $1.53
Sga Expense Q3 2022 · Sep 30, 2022 $130.36M
Sga Expense Q3 2022 · Sep 30, 2022 $409.56M
Sga Expense Q3 2022 · Sep 30, 2021 $139.52M
Sga Expense Q3 2022 · Sep 30, 2021 $421.51M
Net Income Q3 2022 · Sep 30, 2022 $87.05M
Net Income Q3 2022 · Sep 30, 2022 $210.97M
Net Income Q3 2022 · Sep 30, 2021 $78.24M
Net Income Q3 2022 · Sep 30, 2021 $158.87M
Operating Income Q3 2022 · Sep 30, 2022 $117.84M
Operating Income Q3 2022 · Sep 30, 2022 $308.34M
Operating Income Q3 2022 · Sep 30, 2021 $113.36M
Operating Income Q3 2022 · Sep 30, 2021 $258.06M
Revenue Q3 2022 · Sep 30, 2022 $1.34B
Revenue Q3 2022 · Sep 30, 2022 $4.03B
Revenue Q3 2022 · Sep 30, 2021 $1.35B
Revenue Q3 2022 · Sep 30, 2021 $3.84B